-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/pbt-lsr-draft-report.pdf
February 04, 2022 - ) Cannabis Products ..... 23
Summary of Findings for Whole-Plant Cannabis and Mixed (Patient-Choice) … • Evidence on whole-plant cannabis (including patient’s choice of products), low THC to
CBD ratio … Key Points for Whole-Plant Cannabis and Mixed (Patient-Choice)
Cannabis Products
• No new studies … evaluated whole-plant cannabis or mixed (patient-choice) cannabis
products … evaluated whole-plant cannabis or mixed (patient-choice) cannabis products.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
October 01, 2018 - the EPC report and asked about what other
information they require to make their decisions about choice … clinicians were instructed to ask patients for the issue most important to them when making a
treatment choice … The
diabetes mellitus medication choice decision aid:
a randomized trial.
-
effectivehealthcare.ahrq.gov/products/advanced-care-decision-aids/technical-brief
July 29, 2014 - Current Page Topic Timeline Dec. 22, 2011 Topic Suggestion Dec. 10, 2013 Research Protocol Jul. 29, 2014 Technical Brief Nov. 3, 2014 Disposition of Comments Report Decision Aids for Advance Care Planning
Technical Brief Archived July 29, 2014 Web Version [NLM Site] Download Main Document PDF 511.4 KB
…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-250-cannabis-other-plant-based-treatments-evidence-summary.pdf
October 01, 2021 - • Evidence on whole-plant cannabis (including patient’s choice of products), low-
THC to CBD ratio … CBD THC Synthetic THC
THC to CBD Ratio Unclear High High
Source Any cannabis product
(patient’s choice
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-evidence-summary_0.pdf
October 01, 2021 - • Evidence on whole-plant cannabis (including patient’s choice of products), low-
THC to CBD ratio … CBD THC Synthetic THC
THC to CBD Ratio Unclear High High
Source Any cannabis product
(patient’s choice
-
effectivehealthcare.ahrq.gov/sites/default/files/hunt_panel_1.pdf
January 01, 2010 - Hunt_Panel_1
Slide
1: Helping
People
Make
Better Health Care
Choices: Why
Web 2.0?
Yvonne Hunt, Ph.D., M.P.H.
Cancer Prevention Fellow
National Cancer Institute, Bethesda, MD
Slide
2: Untitled
page from the smokefree.gov Web site.
Slide
3…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/quantitative-synthesis-expanded-methods_methods.pdf
March 01, 2013 - 14
percent, 13 percent or 31 percent of 115 meta-analyses of binary outcomes when the measure of
choice … Explanation of choice
of effect measure
Specify what type of outcome data is being combined (e.g … If the study design allows a choice
of effect measure then choose the one that best answers the
research … question and provide a rationale for that choice.
14
Table 2. … Provide interpretation for the individual and combined study estimates based on
the type of data and choice
-
effectivehealthcare.ahrq.gov/sites/default/files/deliberative-methods-facilitation-slides-text.pdf
January 11, 2017 - Concerns about loss of patient/doctor authority
o How people balance the tension between personal choice
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
January 01, 2016 - Lesion characteristics such as size, location,
and type (e.g., superficial, deep) also influence the choice … timolol, while deep lesions are less likely to respond.13
Intralesional steroids may be the drug of choice … discovery of its effects on IH lesions in
2008.17 Prior to this, corticosteroids were the drug of
choice … , but propranolol has become the typical choice
for initial medical management in children without … Lesion characteristics also influence the
choice of specific pharmacologic agents.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/public-reporting-quality-improvement_disposition-comments.pdf
July 26, 2012 - routinely have publicly reported scores for individual providers, this point
about informing consumer choice … emergency or
based on a doctor's referral or in a one-hospital region, the consumer
isn't making a choice … Additional text has
been added explaining that no guidance or prior
practice dictated the choice of … Section Comment Response
Peer Reviewer 5 Results 1) KQ4: impact on patients: be clear about patient choice … 2) Line 23-34: ‘one reason..’ is unclear how volume and market share is
associated with consumer choice
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/statistical-inference_research.pdf
April 01, 2013 - The current results imply that
the choice of effect size metrics, estimators, and sampling variances … Findings relevant to meta-analytic practice (effect size and variance choice) ................30 … If meta-analytic statistics and inferences do depend on choice of unstandardized vs. … Choice of Metric When Meta-Analyzing Continuous Measures
Although several statistical methods exist … Findings relevant to meta-analytic practice (effect size and variance choice)
Design Type Inferential
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_2-user-guide-to-ocer_130129.pdf
January 01, 2011 - 21
Abstract
The choice of study design often has profound consequences for the causal interpretation … The choice of study design often has profound
consequences for the causal interpretation of study
results … treatments
and outcomes of interest, as well as the predictors
of outcome risk potentially related to choice … Choice of Comparators
Both confounding by indication and confounding
by frailty may be strongest and … Therefore, the
choice of an appropriate study design is at least
as important, if not more important
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
January 03, 2012 - Comparison Groups
An important choice in study design is the
selection of suitable treatment and … useful to explore
these subpopulations to determine if the overall
associations persist or if the best choice … Samy Suissa illustrated how the choice of cohort
definition can affect effect estimates in his
paper … The precise choice of transformation requires
knowledge of the distribution of the covariate. … • Does the choice of statistical method influence
the directionality or strength of the association
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
June 01, 2012 - The choice of NIT may differ by clinician preference,
availability, or setting (outpatient vs. chest … probability, most clinicians would prefer to have
patients undergo one NIT prior to determining a treatment
choice … Choice of NIT—
and whether to use exercise or pharmacological stress
imaging—may be influenced by functional … Noncomparative studies have selection, spectrum,
and intervention biases for the following reasons: The
choice … The
information from these clinical trials could inform how
the choice of an NIT modality affects prognosis
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
December 01, 2017 - For these reasons, the evidence is insufficient
to inform choice of expectant management over other … information is required as a first
step towards using individual characteristics to inform
treatment choice … were randomly assigned to the intervention received,
provider and patient biases in intervention choice
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/test-performance-metrics_appendixes.pdf
January 01, 2005 - informative tests.3 We note that other, more lenient boundaries for
LR+ and LR- can be used3 and that the choice
-
effectivehealthcare.ahrq.gov/sites/default/files/s1.pdf
October 01, 2007 - resulting from
the adverse drug effects of medications, suboptimal treatment response, inappropriate
choice
-
effectivehealthcare.ahrq.gov/sites/default/files/lung-cancer-staging_executive.pdf
April 01, 2016 - dismal at about
6 percent.1
Staging involves determining the extent
of disease and guides the choice … Choice of treatment (e.g., surgery, chemotherapy,
radiation)
b. Timeliness of treatment
c. … of test (or test strategy) might influence choice of
treatment, timeliness of treatment, harms due … • For comparative choice of treatment (part of KQ2),
this means reporting the percentage of patients … who
received a specific treatment choice for one test
or test strategy compared with another test
-
effectivehealthcare.ahrq.gov/products/payer-usability/white-paper
February 03, 2014 - Payer Perspectives on Improving Usability of Effective Health Care Products: Bridging the Gap Between Information Needs and Evidence Translation
White Paper February 3, 2014 Download Main Document PDF 294 KB
This report is available in PDF (294 kB) only. People using assistive technology may not be ab…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
September 01, 2012 - Unresolved issues about choice of progestogen,
optimal route of drug delivery, and other candidate high … Ultimately, providing data to support
choice of an optimal form of progestogen, to determine
whether